Idh-mutant Glioma
📧 Sign up to get email alerts when something new happens for Idh-mutant Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas [NA]
A completed trial evaluating temporally-modulated pulsed radiation therapy after prior EBRT in adults with recurrent IDH-mutant gliomas, inc…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation [Phase 3]
A Phase 3 trial evaluating vorasidenib for Asian participants with residual or recurrent grade 2 IDH-mutant glioma is currently active but n…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Nivolumab for Recurrent or Progressive IDH Mutant Gliomas [Phase 2]
Phase 2 trial of nivolumab for recurrent or progressive IDH-mutant gliomas has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Olaparib in Recurrent IDH-mutant Glioma [Phase 2]
Phase 2 trial of olaparib in recurrent IDH-mutant glioma has been completed.